MicroRNA‑21‑5p acts via the PTEN/Akt/FOXO3a signaling pathway to prevent cardiomyocyte injury caused by high glucose/high fat conditions

MLA

Ying, Han, et al. “MicroRNA‑21‑5p Acts via the PTEN/Akt/FOXO3a Signaling Pathway to Prevent Cardiomyocyte Injury Caused by High Glucose/High Fat Conditions.” Experimental and Therapeutic Medicine, vol. 23, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....57503c7dbfbb0b9509940a92162c6bab&authtype=sso&custid=ns315887.

APA

Ying, H., Xiaoqi, C., Min, P., Jin, G., Wenqin, C., Dan, L., & Changsheng, X. (2022). MicroRNA‑21‑5p acts via the PTEN/Akt/FOXO3a signaling pathway to prevent cardiomyocyte injury caused by high glucose/high fat conditions. Experimental and Therapeutic Medicine, 23.

Chicago

Ying, Han, Cai Xiaoqi, Pan Min, Gong Jin, Cai Wenqin, Lu Dan, and Xu Changsheng. 2022. “MicroRNA‑21‑5p Acts via the PTEN/Akt/FOXO3a Signaling Pathway to Prevent Cardiomyocyte Injury Caused by High Glucose/High Fat Conditions.” Experimental and Therapeutic Medicine 23 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....57503c7dbfbb0b9509940a92162c6bab&authtype=sso&custid=ns315887.